机译:Neoadjuvant Chemoraradiation疗法治疗阶段II / III阶段患者辅助化疗的疗效
Ohio State Univ Comprehens Canc Ctr Div Med Oncol Columbus OH 43210 USA;
Ohio State Univ Comprehens Canc Ctr Div Med Oncol Columbus OH 43210 USA;
Ohio State Univ Dept Biostat Columbus OH 43210 USA;
Ohio State Univ Comprehens Canc Ctr Div Radiat Oncol Columbus OH 43210 USA;
Ohio State Univ Comprehens Canc Ctr Div Radiat Oncol Columbus OH 43210 USA;
Ohio State Univ Comprehens Canc Ctr Div Surg Oncol Columbus OH 43210 USA;
Ohio State Univ Comprehens Canc Ctr Div Surg Oncol Columbus OH 43210 USA;
Ohio State Univ Comprehens Canc Ctr Div Surg Oncol Columbus OH 43210 USA;
Ohio State Univ Comprehens Canc Ctr Div Surg Oncol Columbus OH 43210 USA;
Ohio State Univ Comprehens Canc Ctr Div Med Oncol Columbus OH 43210 USA;
Ohio State Univ Comprehens Canc Ctr Div Med Oncol Columbus OH 43210 USA;
rectal cancer; adjuvant chemotherapy; survival; neoadjuvant chemoradiation;
机译:Neoadjuvant Chemoraradiation疗法治疗阶段II / III阶段患者辅助化疗的疗效
机译:新辅助校长后病理完全反应延迟手术和辅助化疗延迟手术和辅助化疗的生存影响
机译:与首先进行手术和进行辅助化疗相比,接受新辅助化疗的III期胰腺腺癌患者的总体生存率有所提高:有意治疗国家癌症数据库的分析
机译:细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
机译:金斯敦地区癌症中心(安大略省)对III期非小细胞肺癌患者进行化学放射治疗的有效性。
机译:新辅助放化疗治疗II / III期切除直肠癌患者的辅助化疗疗效
机译:淋巴结转移率对ypstage III直肠癌患者肿瘤学结局的影响,新辅助放化疗,全直肠系膜切除术和术后辅助化疗。